9th Annual Biomarkers Congress

Biotechnology: Memorial Sloan-Kettering Cancer Center

Total Score People Score Events Score
24 24 2
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings CANCER EVOLUTION AND RESISTANCE Neal Rosen
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Hans-Guido Wendel
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY Jedd D. Wolchok, Margaret Callahan
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Chris Sander
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Douglas A. Levine
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO James P Allison
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James A. Fagin
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Clinical Trials Based on Mutations versus Histology Charles L Sawyers
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Neal Rosen
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Andrea Ventura
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY David C Lyden
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA Victoria M. Richon
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY Johanna A. Joyce
December 1, 2007 47TH American Socieity of Cell Biology Getting In Shape: New Clues From the Fly Embryo Jennifer A Zallen
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. S. Larochelle, R P Fisher
The Cell Biology of Embryonic Patterning and Morphogenesis in the Mouse Embryo Kathryn V. Anderson, Josh Bloomekatz, Isabelle Migeotte
Binding of the HBV X Protein to hBubR1 Disturbs the Mitotic Checkpoint and Increases Chromosome Instability Jeff Lee
Polarized Cell Behavior during Axis Elongation in Drosophila. Jennifer A Zallen, J Blankenship, J S P. Sanny, O Weitz
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.